Design of (N)-methanocarba adenosine 5′-uronamides as species-independent A3 receptor-selective agonists
- 4 April 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (9) , 2813-2819
- https://doi.org/10.1016/j.bmcl.2008.04.001
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The anti-inflammatory effect of A3adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritisExpert Opinion on Investigational Drugs, 2007
- N6-Methoxy-2-alkynyladenosine Derivatives as Highly Potent and Selective Ligands at the Human A3Adenosine ReceptorJournal of Medicinal Chemistry, 2007
- The Sonogashira Reaction: A Booming Methodology in Synthetic Organic ChemistryChemical Reviews, 2007
- Cl-IB-MECA [2-Chloro-N6-(3-iodobenzyl)adenosine-5′-N-methylcarboxamide] Reduces Ischemia/Reperfusion Injury in Mice by Activating the A Adenosine ReceptorThe Journal of Pharmacology and Experimental Therapeutics, 2006
- The synthesis of highly potent, selective, and water-soluble agonists at the human adenosine A3 receptorBioorganic & Medicinal Chemistry Letters, 2006
- Adenosine in Tissue Protection and Tissue RegenerationMolecular Pharmacology, 2005
- Analysis of calcium responses mediated by the A3 adenosine receptor in cultured newborn rat cardiac myocytesCell Calcium, 2004
- Animal models for the study of adenosine receptor functionJournal of Cellular Physiology, 2004
- 2-Pyrazolyl-N6-Substituted Adenosine Derivatives as High Affinity and Selective Adenosine A3Receptor AgonistsJournal of Medicinal Chemistry, 2004
- Adenosine A 3 Receptor Activation Modulates the Capillary Endothelial GlycocalyxCirculation Research, 2004